Neon’s Personal Neoantigen Vaccine Trial Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, NSCLC and Bladder Cancer – CBI
Homepage/Press Release/Neon’s Personal Neoantigen Vaccine Trial Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, NSCLC and Bladder Cancer
Press Release
Neon’s Personal Neoantigen Vaccine Trial Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, NSCLC and Bladder Cancer
